Cancer researchers hit a bullseye with new drug target for Ewing sarcoma

Researchers have found that Ewing sarcoma cells die if an enzyme called CDK12 is knocked out genetically or chemically inhibited. What’s more, when a CDK12 inhibitor is combined with another drug, called a PARP inhibitor, the two drugs double down to deliver a lethal punch to Ewing sarcoma cells.

🕐 Top News in the Last Hour By Importance Score

#	Title	📊 i-Score
1	Chevron Must Pay $745 Million for Coastal Damages, Louisiana Jury Rules	🟢 85 / 100
2	Torrential rain and flash flooding follow deadly tornadoes as storms rage in central US	🟢 85 / 100
3	Empire star Terrence Howard makes shock claim about Diddy ahead of disgraced mogul's sex trafficking trial	🟢 82 / 100
4	How paracetamol could be destroying your fertility: Sperm counts are plummeting. Now scientists say painkillers can build up in the body… and for pregnant women the effects could be disastrous	🔴 78 / 100
5	Women's disc golfer refuses to face trans rival as shock video shows her furious exit from competition	🔴 72 / 100
6	For the age of Amorim, this Manchester derby feels like a decisive moment	🔴 65 / 100
7	Conservative woman hits entitled trans person with brutal truth… and the internet goes wild	🔵 55 / 100
8	Michelle Williams Says She Knew 'Brokeback Mountain' Was 'Special'	🔵 52 / 100
9	Narcos: Mexico's Manuel Masalva in Coma After Contracting Infection	🔵 45 / 100
10	More Grocery Stores That Are Also Great Restaurants	🔵 40 / 100

View More Top News ➡️